Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
Regulatory decision-making depends on evidence that reflects how medical products perform in...
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
Liver disease is a growing global health concern, yet many of its most serious forms remain under-recognized and underdiagnosed. Metabolic dysfunction-associated steatohepatitis (MASH) stands out as a particularly urgent challenge. MASH disease is a ...